PANAXIA LABS ISRAEL LTD Inactive Instrument
Panaxia Labs Israel Ltd Share Price TEL AVIV STOCK EXCHANGE
Equities
PNAX
IL0011043630
Business Support Services
| Sales 2022 | 39.42M 10.35M 863M | Sales 2023 | 19.59M 5.15M 429M | Capitalization | 22.44M 5.89M 492M |
|---|---|---|---|---|---|
| Net income 2022 | -43M -11.29M -942M | Net income 2023 | -13M -3.41M -285M | EV / Sales 2022 | 1.63 x |
| Net Debt 2022 | 36.12M 9.49M 791M | Net Debt 2023 | 36.1M 9.48M 791M | EV / Sales 2023 | 2.99 x |
| P/E ratio 2022 |
-0.65
x | P/E ratio 2023 |
-168
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 37.69% |
More Fundamentals
* Assessed data
More news
| Managers | Title | Age | Since |
|---|---|---|---|
Dadi Segal
CEO | Chief Executive Officer | 48 | 01/19/01 |
Assi Rotbart
CHM | Chairman | 49 | 01/19/01 |
| Director of Finance/CFO | 66 | 28/22/28 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Michal Yageel
BRD | Director/Board Member | 53 | 29/21/29 |
Tal Yaron Eldar
BRD | Director/Board Member | 60 | 21/16/21 |
Michal Sapir
BRD | Director/Board Member | 66 | 17/22/17 |
Panaxia Labs Israel Ltd is an Israel-based company that is principally engaged in cannabis industry. The Company provides pharma-grade smokeless cannabis products that provide better delivery systems for patients and physicians when properly assessing safety and dosage. Panaxia pharmaceutical cannabis products are specifically tailored to meet a broad range of needs. It's product portfolio includes: NAXIVA-PANAXOL Advanced kit for preparation of cannabis oil-standardized extract, NAXIVA-PANAXOL Purified extract for inhalation, PANAXIR Medical Cannabis Orodispersible Tablets, PANAXIR SENSE Orange Creamsicle Medical cannabis sublingual drops, PANAXIR CBD Melatonin Tablets, PANAXIR Medical cannabis extracts in ethanol among others.
Sector
Business Support Services
| 1st Jan change | Capi. | |
|---|---|---|
| +10.55% | 67.6B | |
| +11.64% | 18.21B | |
| +21.03% | 13.41B | |
| +9.40% | 13.37B | |
| +16.53% | 9.94B | |
| -32.90% | 5.74B | |
| -10.98% | 5.57B | |
| -4.09% | 4.91B | |
| -4.83% | 4.87B |
